State of Stanford Medicine
At the annual state of Stanford Medicine address, leaders unveiled plans to refresh the integrated strategic plan and to continue implementing the Commission on Justice and Equity’s recommendations.
Stanford Medicine gives to the community
Stanford Medicine donated more than $950 million in funds and services during the 2022 fiscal year, focusing on access to health care, housing and nutrition.
Long-COVID clinical trials underway
Developing the right treatment for long COVID depends on figuring out what’s causing it. Stanford Medicine researchers are bent on learning more about the people who have it to find out.
New app detects mpox
Researchers were able to devise an app that can determine which skin lesions are caused by mpox with an accuracy of 90%.
Racing heart drives anxiety in mice
Using pulses of light to control heart rate, Stanford Medicine researchers investigate a long-standing mystery about how physical states influence emotions.
Cancer cells become cancer cure
Researchers found that when they turned cancer cells into immune cells, they were able to teach other immune cells how to attack cancer.
Hemorrhage toolkit is cost-effective
A statewide quality-improvement project to treat excessive bleeding during childbirth averts $9 million annually in California’s health care costs, a Stanford Medicine-led study found.
Cyclotron director dies at 43
The director of the Stanford Medicine cyclotron and radiochemistry facility died on Jan. 25. He created novel radiotracers for clinical and research use.
African-American Alzheimer’s risk factor
A genetic risk factor found virtually exclusively among people of at least partial African ancestry substantially boosts the risk of incurring Alzheimer’s disease — but only sometimes.
Nobelist Paul Berg dies
Credited with sparking the field of genetic engineering, Stanford Medicine biochemist Paul Berg shared the 1980 Nobel Prize in chemistry for creating the first recombinant DNA molecule.